MedTrace Logo

Intracutaneous Delivery of Varied Dose Volumes of Saline

NCT01767337 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2017-08-02

No results posted yet for this study

Summary

This study will evaluate intracutaneous delivery of 0.1, 0.25 and 0.5 milliliter volumes of saline from the FLUGEN 101.2 investigational microneedle-based device.

Conditions

Interventions

DEVICE

FLUGEN 101.2 device

Sponsors & Collaborators

  • Accelovance

    collaborator INDUSTRY

  • FluGen Inc

    lead INDUSTRY

Principal Investigators

  • Renee Herber · FluGen Inc

  • Murray A Kimmel, DO · Accelovance

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
49 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-12-31
Primary Completion
2012-12-31
Completion
2012-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01767337 on ClinicalTrials.gov